Holen Sie sich die Stockscreener-App
492.51
1.09%
5.29
Handel nachbörslich:
493.70
1.19
+0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$487.22
Offen:
$482.17
24-Stunden-Volumen:
4.18M
Relative Volume:
1.88
Marktkapitalisierung:
$183.03B
Einnahmen:
$45.20B
Nettoeinkommen (Verlust:
$6.87B
KGV:
27.08
EPS:
18.1888
Netto-Cashflow:
$6.75B
1W Leistung:
+9.87%
1M Leistung:
+5.63%
6M Leistung:
-16.64%
1J Leistung:
+21.98%
1-Tages-Spanne:
$481.03
$499.00
1-Wochen-Bereich:
$443.61
$499.00
52-Wochen-Spanne:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
492.51 | 181.06B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
182.67 | 127.84B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.53 | 44.81B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.53 | 38.21B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
383.57 | 36.00B | 3.77B | 449.25M | 240.68M | 7.8556 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Unveils AI Orbitraps And Swedish Labs As Valuation Lags - Yahoo Finance
Thermo Fisher Rose 10% This Week. Here’s What to Expect in 2026 - TIKR.com
Thermo Fisher Beats Black Worker’s Race, Sex Discrimination Suit - Bloomberg Law News
Thermo Fisher Scientific Hits Day High with 6.8% Intraday Surge - Markets Mojo
Fidelity files Form 144: TMO proposed sale of 45,940 shares (05/29/2026) - Stock Titan
Is Thermo Fisher Scientific Stock Underperforming the S&P 500? - Yahoo Finance
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Stock Up 6.8% and Still Under - GuruFocus
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 5.14% on May 28: Drivers Behind the Movement - TradingKey
Thermo Fisher Launches E-Gel Power Snap Lite System - Contract Pharma
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 — Data Talk - Morningstar
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 -- Data Talk - Moomoo
Thermo Fisher (TMO) Unveils Advanced Mass Spectrometers at Key C - GuruFocus
New Thermo Fisher AI tools aim to speed drug discovery workflows - Stock Titan
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating? - Insider Monkey
Thermo Fisher (TMO) Sets a Bold 7% Annual Growth Target at Its 2026 Investor Day - Insider Monkey
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $650 - Moomoo
[144] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor DaySlideshow (NYSE:TMO) 2026-05-26 - Seeking Alpha
Thermo Fisher Scientific (TMO) Announces Results of Annual Share - GuruFocus
KeyBanc reiterates Thermo Fisher Scientific stock rating on AI tailwinds By Investing.com - Investing.com Canada
Thermo Fisher Scientific Inc. 8-K SEC Filing Details, Exchange Listings, and Security Information (May 20, 2026) - Minichart
Thermo Fisher Scientific Inc (TMO) Stock Price, Trades & News - GuruFocus
Thermo Fisher (NYSE: TMO) holders back board but reject 2026 executive pay proposal - Stock Titan
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Ambient Air Quality Monitoring is Helping Cities Tackle Urban Pollution - AZoCleantech
Thermo Fisher Scientific Inc. (TMO) Announces Opening of New Bioanalytical and Biomarker Laboratory in Gothenburg, Sweden - Insider Monkey
Thermo Fisher Scientific Inc Investor Day Transcript - GuruFocus
Did Thermo Fisher’s AI-Focused Investor Day and Clario Deal Just Redefine TMO’s Investment Narrative? - simplywall.st
Thermo Fisher (TMO) director gets 499-share award, 80 withheld for tax - Stock Titan
Director at Thermo Fisher (NYSE: TMO) granted new shares - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share stock award - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share equity grant - Stock Titan
Thermo Fisher (TMO) director receives 499-share stock grant, now holds 2,602 - Stock Titan
Thermo Fisher (TMO) director Tyler Jacks receives 499-share stock grant - Stock Titan
Director at Thermo Fisher (NYSE: TMO) awarded 499 common shares - Stock Titan
Thermo Fisher (TMO) director Ruby R. Chandy receives 499-share stock grant - Stock Titan
Director at Thermo Fisher (NYSE: TMO) receives 499-share stock grant - Stock Titan
Nuvation Bio (NUVB) Collaborates with Thermo Fisher - Insider Monkey
What Thermo Fisher CEO Said at Investor Day That the Market Is Still Processing - TIKR.com
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $600 to $630 - Moomoo
Stifel Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $600 - Moomoo
Thermo Fisher Scientific To Go Ex-Dividend On June 15th, 2026 With 0.47 USD Dividend Per Share - Moomoo
What Thermo Fisher Scientific (TMO)'s New Gothenburg Lab Expansion Means For Shareholders - Yahoo Finance
D1 Capital Partners L.P.'s Thermo Fisher Scientific Inc(TMO) Holding History - GuruFocus
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Thermo Fisher Scientific Inc. Balance Sheet – BVL:TMOUS - TradingView
Automated Microbiology Market to Reach USD 13.50 Billion by 2033 - openPR.com
Thermo Fisher Scientific’s SWOT analysis: stock navigates growth amid strategic shifts - Investing.com
High-Throughput Screening (HTS) Market Research Report to 2032 - openPR.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):